Automated Sample Storage Systems Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Automated sample storage systems integrate robotic handling, software tracking, and ultra-low or cryogenic refrigeration to manage large volumes of biological and chemical samples. The global market is estimated near USD 1.6 billion in 2025 and is projected to reach roughly USD 4-5 billion by 2035. Demand is concentrated among pharmaceutical companies, academic and government biobanks, contract research organizations, and hospitals handling high-value specimens.

• •Estimated 2025 market size: approximately USD 1.6 billion worldwide
• •Projected long-term CAGR: ~10.5%, with potential to exceed USD 4 billion by the mid-2030s
• •Core end users: pharmaceutical R&D, biobanks, CROs, academic and clinical research labs

The expansion of population-scale and disease-specific biobanks is generating sustained demand for high-capacity, traceable storage. Pharmaceutical and biotechnology companies are scaling up R&D pipelines, particularly in cell and gene therapies, which require tightly controlled cryogenic environments. At the same time, laboratories are automating workflows to address labor shortages, reduce manual errors, and meet stricter regulatory standards for sample integrity.

• •Rising biobanking activity for genomics, precision medicine, and clinical research
• •Growth of cell, gene, and biologic therapies requiring cryogenic storage
• •Increasing laboratory automation to improve throughput and regulatory compliance

The market is commonly segmented by sample type (biological vs. chemical), temperature range (room temperature, refrigerated, -20°C, -80°C, and cryogenic/vapor-phase nitrogen), and end user. By storage temperature, ultra-low and cryogenic systems typically hold the largest revenue share because of their role in preserving DNA, RNA, cells, and tissues. Geographically, North America leads in installed base and revenue, supported by mature biobanking networks, while Europe holds a strong second position, and Asia-Pacific is the fastest-growing region as China, India, and Japan expand research infrastructure.

• •Ultra-low and cryogenic storage systems represent the largest revenue segment
• •North America leads the market; Europe holds significant share; Asia-Pacific is growing fastest
• •Pharmaceutical and biotech companies account for the dominant share of end-user spending

What are the recent trends and outlook?

Vendors are embedding IoT sensors, cloud-based sample management platforms, and AI-driven inventory analytics to support predictive maintenance and chain-of-custody audits. Modular and scalable storage formats are gaining traction as biobanks expand incrementally rather than in single large builds. Over the next decade, the market is expected to continue outpacing general laboratory equipment growth, supported by new therapy pipelines and the global build-out of biobanking capacity.

• •Adoption of IoT monitoring, cloud LIMS integration, and AI-based sample analytics
• •Shift toward modular, scalable storage architectures for flexible biobank expansion
• •Strong long-term outlook driven by precision medicine, cell and gene therapy, and global biobank investment